TREATMENT WITH THE CHIMERIC ANTI-IL-2Rα ANTIBODY...

TREATMENT WITH THE CHIMERIC ANTI-IL-2Rα ANTIBODY BASILIXIMAB (SIMULECT®) AFFECTS BOTH THE IL-2 AND THE IL-15 SIGNALING PATHWAY AFTER CLINICAL KIDNEY TRANSPLANTATION.

Baan, Carla C., Riemsdijk, Iza C. van, Haperen, Maud J.A.M. Boelaars-van, IJzermans, Jan N.M., Weimar, Willem
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
69
Journal:
Transplantation
DOI:
10.1097/00007890-200004271-00570
Date:
April, 2000
File:
PDF, 731 KB
2000
Conversion to is in progress
Conversion to is failed